Rafferty Asset Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $2.82 Million - $2.96 Million	19,423 Added 73.35%	45,902 $6.94 Million
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $1.54 Million - $2.7 Million	-18,522 Reduced 41.16%	26,479 $3.86 Million
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $866,880 - $1.13 Million	-7,875 Reduced 14.89%	45,001 $5.34 Million
Q4 2021 Feb 10, 2022	BUY	$99.73 - $148.48 $2.96 Million - $4.41 Million	29,720 Added 128.35%	52,876 $7.29 Million
Q3 2021 Nov 10, 2021	SELL	$98.85 - $138.91 $166,166 - $233,507	-1,681 Reduced 6.77%	23,156 $3.22 Million
Q2 2021 Aug 10, 2021	SELL	$65.78 - $105.02 $1.05 Million - $1.68 Million	-16,031 Reduced 39.23%	24,837 $2.41 Million
Q1 2021 May 10, 2021	BUY	$64.07 - $91.75 $1.93 Million - $2.77 Million	30,188 Added 282.66%	40,868 $2.79 Million
Q4 2020 Feb 10, 2021	SELL	$65.07 - $98.24 $1.49 Million - $2.25 Million	-22,928 Reduced 68.22%	10,680 $915,000
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $1.13 Million - $1.49 Million	19,137 Added 132.24%	33,608 $2.19 Million
Q2 2020 Aug 07, 2020	BUY	$29.01 - $74.23 $221,375 - $566,449	7,631 Added 111.56%	14,471 $1.06 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $1.41 Million - $2.93 Million	-51,203 Reduced 88.22%	6,840 $233,000
Q4 2019 Feb 10, 2020	SELL	$40.86 - $57.65 $2.77 Million - $3.9 Million	-67,735 Reduced 53.85%	58,043 $3.16 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $1.81 Million - $2.4 Million	48,518 Added 62.8%	125,778 $5.25 Million
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $833,640 - $1.4 Million	20,951 Added 37.21%	77,260 $3.38 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $1.94 Million - $3 Million	56,309 New	56,309 $2.9 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account